Denise Kelly
Corporate Officer/Principal bei Seventure Partners SA
Profil
Denise Kelly is the founder of GT Biologics Ltd., a company founded in 2008.
She held the title of Director & Chief Scientific Officer from 2008 to 2011.
Currently, Dr. Kelly is an Advisor at Seventure Partners SA, starting in 2015.
She also previously worked as a Principal at The Rowett Research Institute.
Aktive Positionen von Denise Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Corporate Officer/Principal | 21.03.2019 |
Ehemalige bekannte Positionen von Denise Kelly
| Unternehmen | Position | Ende |
|---|---|---|
The Rowett Research Institute
 The Rowett Research Institute Miscellaneous Commercial ServicesCommercial Services Part of University of Aberdeen, The Rowett Research Institute engages in conducting research to help in solving nutritional problems. The company is based in Aberdeen, UK. Founded in 1962. | Corporate Officer/Principal | - |
GT Biologics Ltd.
 GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology GT Biologics Ltd. manufactures and distributes pharmaceutical products. It develops and commercializes an oral-based probiotic product for the treatment of mild to moderate Crohn's disease and ulcerative colitis and a novel family of protein, peptide therapeutics for the treatment of moderate to severe inflammatory bowel diseases. The company was founded by Denise Kelly in 2008 and is headquartered in Leeds, the United Kingdom. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
GT Biologics Ltd.
GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology GT Biologics Ltd. manufactures and distributes pharmaceutical products. It develops and commercializes an oral-based probiotic product for the treatment of mild to moderate Crohn's disease and ulcerative colitis and a novel family of protein, peptide therapeutics for the treatment of moderate to severe inflammatory bowel diseases. The company was founded by Denise Kelly in 2008 and is headquartered in Leeds, the United Kingdom. | Health Technology |
The Rowett Research Institute
The Rowett Research Institute Miscellaneous Commercial ServicesCommercial Services Part of University of Aberdeen, The Rowett Research Institute engages in conducting research to help in solving nutritional problems. The company is based in Aberdeen, UK. Founded in 1962. | Commercial Services |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
